Premium
Stem cells for spinal cord injury: Strategies to inform differentiation and transplantation
Author(s) -
Iyer Nisha R.,
Wilems Thomas S.,
SakiyamaElbert Shelly E.
Publication year - 2017
Publication title -
biotechnology and bioengineering
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.136
H-Index - 189
eISSN - 1097-0290
pISSN - 0006-3592
DOI - 10.1002/bit.26074
Subject(s) - stem cell , spinal cord injury , transplantation , neuroscience , biology , regeneration (biology) , cellular differentiation , microbiology and biotechnology , spinal cord , medicine , genetics , surgery , gene
The complex pathology of spinal cord injury (SCI), involving a cascade of secondary events and the formation of inhibitory barriers, hampers regeneration across the lesion site and often results in irreversible loss of motor function. The limited regenerative capacity of endogenous cells after SCI has led to a focus on the development of cell therapies that can confer both neuroprotective and neuroregenerative benefits. Stem cells have emerged as a candidate cell source because of their ability to self‐renew and differentiate into a multitude of specialized cell types. While ethical and safety concerns impeded the use of stem cells in the past, advances in isolation and differentiation methods have largely mitigated these issues. A confluence of work in stem cell biology, genetics, and developmental neurobiology has informed the directed differentiation of specific spinal cell types. After transplantation, these stem cell‐derived populations can replace lost cells, provide trophic support, remyelinate surviving axons, and form relay circuits that contribute to functional recovery. Further refinement of stem cell differentiation and transplantation methods, including combinatorial strategies that involve biomaterial scaffolds and drug delivery, is critical as stem cell‐based treatments enter clinical trials. Biotechnol. Bioeng. 2017;114: 245–259. © 2016 Wiley Periodicals, Inc.